127378-26-1

Basic information

• Product Name: AKOS B018338
• Synonyms: CHEMBRDG-BB 3018338;ART-CHEM-BB B018338;AKOS B018338;(5E)-2-mercapto-5-(3-methylbenzylidene)-1,3-thiazol-4(5H)-one;Albb-009120;(5E)-2-mercapto-5-(3-methylbenzylidene)-1,3-thiazol-4(5H)-one(SALTDATA: FREE);(5E)-5-(3-methylbenzylidene)-2-thioxo-thiazolidin-4-one;(5E)-5-[(3-methylphenyl)methylene]-2-thioxo-4-thiazolidinone
• CAS NO: 127378-26-1
• Molecular Formula: C₁₁H₉NOS₂
• Molecular Weight: 235.33
• Mol File: 127378-26-1.mol

Chemical Properties

• Boiling Point: 375.1°C at 760 mmHg
• Flash Point: 180.6°C
• Appearance: /
• Density: 1.38g/cm³
• Vapor Pressure: 7.98E-06mmHg at 25°C
• Refractive Index: 1.708
• CAS DataBase Reference: AKOS B018338(CAS DataBase Reference)
• NIST Chemistry Reference: AKOS B018338(127378-26-1)
• EPA Substance Registry System: AKOS B018338(127378-26-1)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 127378-26-1(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Synthesis:
AKOS B018338 is used as a precursor in the synthesis of pharmaceutical compounds for its ability to contribute to the development of new drugs.
Used in Organic Chemical Reactions:
AKOS B018338 is used as a building block in organic chemical reactions, facilitating the creation of various chemical products.
Used in Dye and Pigment Production:
AKOS B018338 is used as a building block in the production of dyes and pigments, contributing to the coloration and properties of these substances.
Used in Enzyme Inhibition:
AKOS B018338 is used as an inhibitor of the enzyme thioredoxin reductase, playing a role in cellular redox regulation and potentially contributing to the development of treatments for diseases associated with redox imbalances.
Used in Organic Chemistry Research:
AKOS B018338 is utilized in the field of organic chemistry research to explore its properties, reactions, and potential applications in creating new chemical entities.

InChI:InChI=1/C11H9NOS2/c1-7-3-2-4-8(5-7)6-9-10(13)12-11(14)15-9/h2-6H,1H3,(H,12,13,14)/b9-6+

Upstream product

• 141-84-4 2-thioxo-4-thiazolidinone 
• 620-23-5 m-tolyl aldehyde 

Relevant articles and documents

Discovery of low-molecular-weight ligands for the AF6 PDZ domain

In the groove: The "drugability" of protein-protein interaction domains is still a matter of debate. The 3D structure of a complex of a small organic ligand and the AF6 PDZ domain revealed the creation of a binding pocket by the ligand (see picture). The

CHARGE CONTROLLING AGENT AND TONER USING SAME

The present invention provides a charge control agent containing, as an active substance(s), one or two or more rhodanine compounds represented by the following formula (1). where R1 represents a hydrogen atom, etc.; R2 represents a hydrogen atom, a linea

Selective small molecule inhibitors of the potential breast cancer marker, human arylamine N-acetyltransferase 1, and its murine homologue, mouse arylamine N-acetyltransferase 2

The identification, synthesis and evaluation of a series of rhodanine and thiazolidin-2,4-dione derivatives as selective inhibitors of human arylamine N-acetyltransferase 1 and mouse arylamine N-acetyltransferase 2 is described. The most potent inhibitors

COMPOUNDS USEFUL AS HYPOGLYCEMIC AGENTS AND FOR TREATING ALZHEIMER'S DISEASE

Provided are methods for treating hyperglycemia and Alzheimer's disease utilizing certain rhodanine derivatives. Certain of the rhodanine derivatives utilized in the instant methods are novel and, accordingly, such compounds and pharmaceutical formulation